Skip to main content

WC3 reassortant vaccines in children

Brief review

  • Conference paper
Viral Gastroenteritis

Part of the book series: Archives of Virology ((ARCHIVES SUPPL,volume 12))

Summary

Bovine rotavirus strain WC3 (P7[5], G6) administered at the 12th passage level was well tolerated clinically in infants and efficiently induced serum virus neutralizing antibody (VNA) with bovine rotavirus G6 specificity. The protective efficacy of WC3 vaccine against all rotavirus disease was inconsistent, varying in four separate trials from 76% to 0%; some selective protection against severe disease was seen in all trials. WC3 reassortants containing the gene for an individual human rotavirus VP7 (G) or VP4 (P) surface antigen were also well tolerated, but preferentially induced VNA to the WC3 parent. Efficacy trials of human G1 VP7 reassortant WI79-9 (P7[5], G1) consistently led to >60% protection against all rotavirus disease. A quadrivalent WC3 reassortant vaccine was developed to contain four separate monovalent reassortants expressing human rotaviruses surface proteins G1, G2, G3, and P1A [8] respectively. In a multicenter trial including 439 infants, this vaccine induced 67.1% protection against all rotavirus disease (defined as positive for rotavirus antigen by ELISA only [p= <0.001]) and 72.6% protection when the standard for rotavirus diagnosis was a positive test of stool for both rotavirus antigen by ELISA and rotavirus RNA by electropherotype analysis (p = < 0.001). In this trial, episodes of the most severe rotavirus disease (clinical severity score > 16.0, eight cases) occurred only in placebo recipients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Acres DS, Radostits OM (1976) The efficacy of a modified live reo-like virus vaccine and an E. coli bacteria for prevention of acute neonatal diarrhea of beef calves. Can Vet J 17: 197–212

    PubMed  CAS  Google Scholar 

  2. Bernstein DI, Smith VE, Sander DS, Pax KS, Schiff GM, Ward RL (1990) Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants. J Infect Dis 162: 1055–1062

    Article  PubMed  CAS  Google Scholar 

  3. Bernstein DI, Glass RI, Rodgers G, Davidson BL, Sack DA (1995) Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in U.S. Children. J Amer Med Assoc 273: 1191–1196

    Article  CAS  Google Scholar 

  4. Bishop RF, Davidson GP, Holmes H, Ruck BJ (1973) Virus particles in epithelial cells of duodenal mucosa from children with viral gastroenteritis. Lancet 2: 1281–1283

    Article  PubMed  CAS  Google Scholar 

  5. Christy C, Madore HP, Treanor JJ, Pray K, Kapikian AZ, Chanock RM, Dolin R (1986) Safety and immunogenicity of live attenuated rhesus monkey rotavirus vaccine. J Infect Dis 154: 1045–1047

    Article  PubMed  CAS  Google Scholar 

  6. Clark HF, Furukawa T, Bell LM, Offit PA, Perrella PA, Plotkin SA (1986) Immune response of infants and children to low-passage bovine rotavirus (strain WC3). Amer J Dis Children 140: 350–356

    CAS  Google Scholar 

  7. Clark HF, Borian EF, Bell LM, Modesto K, Gouvea V, Plotkin SA (1988) Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season. J Infect Dis 158: 750–587

    Article  Google Scholar 

  8. Clark HF, Borian FE, Modesto K, Plotkin SA (1990a) Serotype 1 reassortant of bovine rotavirus WC3, strain WI79-9, induces a polytypic antibody response in infants. Vaccine 8: 327–332

    Article  PubMed  CAS  Google Scholar 

  9. Clark HF, Borian FE, Plotkin SA (1990b) Immune protection of infants against rotavirus gastroenteritis by a serotype 1 reassortant of bovine rotavirus WC3. J Infect Dis 161: 1099–1104

    Article  PubMed  CAS  Google Scholar 

  10. Clark HF, Offit PA (1994) Rotavirus vaccines. In: Plotkin SA, Mortimer EA (eds) Vaccines. Saunders, Philadelphia, pp 809–822

    Google Scholar 

  11. Clark HF, Welsko D, Offit PA (1992) Infant responses to bovine WC3 reassortants containing human rotavirus VP7, VP4, or VP7 & VP4. ICAAC Anaheim, p 343

    Google Scholar 

  12. Clark HF, White CJ, Offit PA, Stinson D, Eiden J, Weaver S, Cho I, Shaw A, Krah D, Ellis R + OHBRV Study Group (1995) Preliminary evaluation of safety and efficacy of quadrivalent human-bovine reassortant rotavirus vaccine. Ped Res 37: 172A

    Google Scholar 

  13. Delem A, Lobmann M, Zygraich N (1984) A bovine rotavirus developed as a candidate vaccine for use in humans. J Biol Stand 12: 443–445

    Article  PubMed  CAS  Google Scholar 

  14. Estes MK, Graham DY, Petrie BL (1985) Antigenic structure of rotaviruses. In: van Regenmortel MHV, Neurath AR (eds) Immunochemistry of viruses. Elsevier, Amsterdam, pp 389–405

    Google Scholar 

  15. Estes MK (1996) Rotaviruses and their replication. In: Fields BN et al. (eds) Virology. Lippincott-Raven Publishers, New York, pp 1625–1655

    Google Scholar 

  16. Garbag-Chenon A, Fontaine J-L, Lasfargues G, Clark HF, Guyot J, LeMoing G, Hessel L, Bricout F (1989) Reactogenicity and immunogenicity of rotavirus WC3 vaccine in 5-12 month old infants. Res Virol 140: 207–217

    Article  PubMed  CAS  Google Scholar 

  17. Georges-Courbot MC, Monges J, Siopathis MR, Roungou JP, Gresenguet G, Bellec L, Bouquety JC, Lanckviet C, Cadoz M, Hessel L, Gouvea G, Clark HF, Georges AJ (1991) Evaluation of the efficacy of a low passage bovine rotavirus (strain WC3) vaccine in children in Central Africa. Res Virol 142: 405–411

    Article  PubMed  CAS  Google Scholar 

  18. Hoshino Y, Wyatt RG, Greenberg HB, Flores J, Kapikian AZ (1984) Serotypic similarity and diversity of rotaviruses of mammalian and avian origin as studied by plaque-reduction neutralization. J Infect Dis 149: 694–702

    Article  PubMed  CAS  Google Scholar 

  19. Institute of Medicine (1986) The prospects for immunzing against rotavirus. In: New vaccine development. Establishing priorities. Diseases of importance in developing countries, vol II. National Academy Press, Washington, DC, pp 308–318

    Google Scholar 

  20. Kobayashi M, Thompson J, Tottlefson SJ, Reed GW, Wright PF (1994) Tetravalent rhesus rotavirus vaccine in young infants. J Infect Dis 170: 1260–1263

    Article  PubMed  CAS  Google Scholar 

  21. Mebus CA, Underdahl NR, Rhodes MB, Twiehaus MJ (1969) Calf diarrhea (Scours): reproduced with a virus from a field outbreak. Nebraska Res Bull 233. Nebraska Agricultural Experiment Station, Lincoln, Nebraska

    Google Scholar 

  22. Mebus CA, White RG, Stair FL, Rhodes MB, Twiehaus MJ (1972) Neonatal calf diarrhea: results of a field trial using a reo-like virus vaccine. Vet Med Ann Clin 67: 173–174

    CAS  Google Scholar 

  23. Midthun K, Greenberg HB, Hoshino Y, Kapikian AZ, Wyatt RG, Chanock RM (1985) Reassortant rotaviruses as potential live rotavirus vaccine candidates. J Virol 53: 949–954

    PubMed  CAS  Google Scholar 

  24. Treanor JJ, Clark HF, Pichichero M, Christy C, Gouvea V, Shrager D, Palazzo S, Offit PA (1995) Evaluation of the protective efficacy of a serotype 1 bovine-human rotavirus reassortant vaccine in infants. Pediatric Infect Dis J 14: 301–397

    Article  CAS  Google Scholar 

  25. Ward RL, Sander DS, Schiff GM, Bernstein DI (1990) Effect of vaccination on serotype-specific antibody responses in infants administered WC3 bovine rotavirus before or after a natural rotavirus infection. J Infect Dis 162: 1298–1303

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag Wien

About this paper

Cite this paper

Clark, H.F. et al. (1996). WC3 reassortant vaccines in children. In: Chiba, S., Estes, M.K., Nakata, S., Calisher, C.H. (eds) Viral Gastroenteritis. Archives of Virology, vol 12. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6553-9_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-6553-9_20

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-82875-5

  • Online ISBN: 978-3-7091-6553-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics